Call for Equitable Drug Access to pre-exposure prophylaxis (PreP) Following Health Canada Approval of APRETUDE by ViiV.

While community-based service providers delivering Canada’s HIV and AIDS response are pleased to learn of APRETUDE ‘s approval, we fear this, and other HIV prevention and treatment medications, will remain inaccessible to many African, Caribbean and Black (ACB) people who continue to experience significant barriers to accessing HIV prevention treatments like APRETUDE, compounded by systemic anti-Black racism within healthcare systems.

Read More →
/

Read the OAN 2022/23 Annual Report 

Following the OAN’s Annual Meeting, we’re pleased to share our annual report summarizing OAN and GMSH activities, outputs, and financials for the 2022/23 fiscal year. In this report, you’ll find a report-back from the co-chairs of the OAN’s Board of Directors, a summary of our financials and funders, and updates about our Skills, PLID, Advocacy, and OPRAH programming.  View Annual Report

Read More →